Carbazeran

CAS No. 70724-25-3

Carbazeran( UK 31557 | UK-31557 | UK31557 | UK 31,557 | UK-31,557 | UK31,557 | )

Catalog No. M27410 CAS No. 70724-25-3

Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 56 In Stock
10MG 88 In Stock
25MG 179 In Stock
50MG 265 In Stock
100MG 398 In Stock
200MG 615 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carbazeran
  • Note
    Research use only, not for human use.
  • Brief Description
    Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
  • Description
    Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UK 31557 | UK-31557 | UK31557 | UK 31,557 | UK-31,557 | UK31,557 |
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    70724-25-3
  • Formula Weight
    360.414
  • Molecular Formula
    C18H24N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 125 mg/mL (346.83 mM)
  • SMILES
    CCNC(=O)OC1CCN(CC1)c1nncc2cc(OC)c(OC)cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jean-Louis H. Dasseux, et al. Ketone compounds and compositions for cholesterol management and related uses. WO2002030860A2.
molnova catalog
related products
  • AWD 12-281

    AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).

  • ONO-6126

    ONO-6126 is a potent and selective PDE4 inhibitor for the treatment of bronchial asthma and allergic conjunctivitis.

  • RPL-554

    RPL-554 (LS-193855, RPL554)?is a potent, orally available, dual PDE3/PDE4 inhibitor with IC50 of 0.4 nM and 1479 nM, respectively.